Papers
1
Total Citations
12
H-Index
1
About
Claudia Wild is a leading health technology assessment (HTA) researcher whose work critically examines the real-world benefits of advanced surgical technologies. Her primary research areas include evidence-based medicine, systematic reviews, and the evaluation of innovative medical devices and procedures. A major contribution is her rigorous analysis of robot-assisted surgery (RAS), where she systematically evaluates whether its high costs translate into tangible patient benefits. Her landmark 2024 systematic review on RAS in thoracic and visceral indications (12 citations) challenges assumptions by revealing that despite technical promises, the evidence for superior patient outcomes over standard care remains unclear. This work exemplifies her commitment to evidence-based policy, often influencing coverage decisions and clinical guidelines. With a career spanning decades, Wild has shaped HTA methodology in Europe, particularly through her leadership at the Austrian Institute for Health Technology Assessment (AIHTA). Her research consistently prioritizes patient-relevant endpoints over technological hype, making her a trusted voice for clinicians and policymakers navigating the adoption of costly surgical innovations.
Research Focus
Key Achievements
Top Papers
- 1